vs

Side-by-side financial comparison of Anterix Inc. (ATEX) and MILESTONE SCIENTIFIC INC. (MLSS). Click either name above to swap in a different company.

MILESTONE SCIENTIFIC INC. is the larger business by last-quarter revenue ($2.1M vs $1.6M, roughly 1.3× Anterix Inc.). MILESTONE SCIENTIFIC INC. runs the higher net margin — -53.0% vs -419.6%, a 366.7% gap on every dollar of revenue. On growth, MILESTONE SCIENTIFIC INC. posted the faster year-over-year revenue change (2.2% vs 0.4%). Over the past eight quarters, Anterix Inc.'s revenue compounded faster (11.7% CAGR vs -4.3%).

Anterix Inc. is a U.S.-headquartered wireless communications company that owns licensed 900 MHz spectrum assets, providing secure, dedicated private broadband network solutions for critical infrastructure operators including electric utilities, public safety agencies, and transportation providers. Its primary market is North America, supporting clients requiring highly reliable connectivity for mission-critical operations.

Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

ATEX vs MLSS — Head-to-Head

Bigger by revenue
MLSS
MLSS
1.3× larger
MLSS
$2.1M
$1.6M
ATEX
Growing faster (revenue YoY)
MLSS
MLSS
+1.8% gap
MLSS
2.2%
0.4%
ATEX
Higher net margin
MLSS
MLSS
366.7% more per $
MLSS
-53.0%
-419.6%
ATEX
Faster 2-yr revenue CAGR
ATEX
ATEX
Annualised
ATEX
11.7%
-4.3%
MLSS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ATEX
ATEX
MLSS
MLSS
Revenue
$1.6M
$2.1M
Net Profit
$-6.6M
$-1.1M
Gross Margin
73.0%
Operating Margin
-576.0%
-52.5%
Net Margin
-419.6%
-53.0%
Revenue YoY
0.4%
2.2%
Net Profit YoY
-185.6%
46.4%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATEX
ATEX
MLSS
MLSS
Q4 25
$1.6M
$2.1M
Q3 25
$1.6M
$2.4M
Q2 25
$1.4M
$2.3M
Q1 25
$1.4M
$2.2M
Q4 24
$1.6M
$2.0M
Q3 24
$1.6M
$2.5M
Q2 24
$1.5M
$1.9M
Q1 24
$1.3M
$2.2M
Net Profit
ATEX
ATEX
MLSS
MLSS
Q4 25
$-6.6M
$-1.1M
Q3 25
$53.5M
$-1.2M
Q2 25
$25.2M
$-1.5M
Q1 25
$9.2M
$-2.0M
Q4 24
$7.7M
$-2.0M
Q3 24
$-12.8M
$-1.5M
Q2 24
$-15.5M
$223.6K
Q1 24
$-9.4M
$-1.4M
Gross Margin
ATEX
ATEX
MLSS
MLSS
Q4 25
73.0%
Q3 25
69.5%
Q2 25
69.6%
Q1 25
73.8%
Q4 24
75.0%
Q3 24
73.0%
Q2 24
76.1%
Q1 24
74.5%
Operating Margin
ATEX
ATEX
MLSS
MLSS
Q4 25
-576.0%
-52.5%
Q3 25
-48.1%
Q2 25
-63.9%
Q1 25
-89.5%
Q4 24
-101.4%
Q3 24
-846.6%
-58.4%
Q2 24
-984.4%
-96.0%
Q1 24
-834.2%
-65.1%
Net Margin
ATEX
ATEX
MLSS
MLSS
Q4 25
-419.6%
-53.0%
Q3 25
3449.5%
-48.9%
Q2 25
1775.7%
-63.8%
Q1 25
662.9%
-89.3%
Q4 24
492.3%
-101.1%
Q3 24
-823.1%
-58.1%
Q2 24
-1018.0%
12.1%
Q1 24
-746.9%
-64.1%
EPS (diluted)
ATEX
ATEX
MLSS
MLSS
Q4 25
$-0.35
Q3 25
$2.86
$-0.01
Q2 25
$1.35
Q1 25
$0.51
Q4 24
$0.41
Q3 24
$-0.69
$-0.02
Q2 24
$-0.84
Q1 24
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATEX
ATEX
MLSS
MLSS
Cash + ST InvestmentsLiquidity on hand
$29.5M
$1.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$236.0M
$2.8M
Total Assets
$417.0M
$7.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATEX
ATEX
MLSS
MLSS
Q4 25
$29.5M
$1.1M
Q3 25
$39.1M
$1.3M
Q2 25
$41.4M
$1.3M
Q1 25
$47.4M
$2.2M
Q4 24
$28.8M
$3.3M
Q3 24
$43.1M
$4.8M
Q2 24
$51.7M
$5.8M
Q1 24
$60.6M
$5.0M
Stockholders' Equity
ATEX
ATEX
MLSS
MLSS
Q4 25
$236.0M
$2.8M
Q3 25
$240.3M
$2.5M
Q2 25
$184.8M
$3.3M
Q1 25
$156.6M
$4.5M
Q4 24
$144.7M
$5.8M
Q3 24
$139.1M
$7.2M
Q2 24
$148.8M
$8.0M
Q1 24
$161.0M
$7.5M
Total Assets
ATEX
ATEX
MLSS
MLSS
Q4 25
$417.0M
$7.8M
Q3 25
$420.4M
$8.5M
Q2 25
$359.6M
$8.1M
Q1 25
$333.1M
$9.1M
Q4 24
$326.7M
$9.8M
Q3 24
$317.2M
$11.2M
Q2 24
$321.1M
$12.0M
Q1 24
$324.9M
$11.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATEX
ATEX
MLSS
MLSS
Operating Cash FlowLast quarter
$-8.3M
$-226.1K
Free Cash FlowOCF − Capex
$-8.3M
FCF MarginFCF / Revenue
-526.4%
Capex IntensityCapex / Revenue
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATEX
ATEX
MLSS
MLSS
Q4 25
$-8.3M
$-226.1K
Q3 25
$1.4M
$81.8K
Q2 25
$-3.1M
$-1.8M
Q1 25
$-16.6M
$-1.0M
Q4 24
$-7.7M
$-1.5M
Q3 24
$-2.6M
$-973.9K
Q2 24
$-2.4M
$783.7K
Q1 24
$6.1M
$-1.2M
Free Cash Flow
ATEX
ATEX
MLSS
MLSS
Q4 25
$-8.3M
Q3 25
Q2 25
Q1 25
$-16.6M
Q4 24
Q3 24
$-2.7M
Q2 24
Q1 24
$6.1M
FCF Margin
ATEX
ATEX
MLSS
MLSS
Q4 25
-526.4%
Q3 25
Q2 25
Q1 25
-1195.2%
Q4 24
Q3 24
-173.4%
Q2 24
Q1 24
484.1%
Capex Intensity
ATEX
ATEX
MLSS
MLSS
Q4 25
0.6%
Q3 25
Q2 25
Q1 25
3.3%
Q4 24
0.0%
Q3 24
2.6%
Q2 24
0.0%
Q1 24
3.2%
Cash Conversion
ATEX
ATEX
MLSS
MLSS
Q4 25
Q3 25
0.03×
Q2 25
-0.12×
Q1 25
-1.80×
Q4 24
-1.00×
Q3 24
Q2 24
3.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons